Wird geladen...
Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy
BACKGROUND: Multi-step testing might enhance performance of the prostate cancer diagnostic pipeline. Using PSA >1 ng/ml for first-line risk stratification and the Stockholm 3 Model (S3M) blood-test >10% risk of Gleason Score > 7 prostate cancer to inform biopsy decisions has been suggested....
Gespeichert in:
| Veröffentlicht in: | BMC Urol |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5627473/ https://ncbi.nlm.nih.gov/pubmed/28974201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-017-0281-8 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|